MEK-InhibitorenRare
Used by 1 of 3.267 companies (0.0%)
startupVerified
Atriva Therapeutics
- Location
- Berlin· Berlin
- Industry
- biopharmaceutical / antiviral / respiratory
- Founded
- 2015
- Employees
- 11-50
- Total funding
- €10.2 Mio
Tech-Stack
Tech stack in context
Each entry is benchmarked against all 3.267 companies in the dataset. Rare items first — those are the more interesting choices.
RareUncommonCommonMainstream
GMPRare
Used by 9 of 3.267 companies (0.3%)
klinische StudienRare
Used by 10 of 3.267 companies (0.3%)
In context
Raw numbers say little — here's how Atriva Therapeutics compares to its industry and city.
Funding position
Top 48%
More funding than 52% of all companies with reported funding.
Industry median: €10.2 Mio
Similar companies
Similar companies
Similar stack
At least 2 shared technologies
- Algiax Pharmaceuticals2 shared techsDüsseldorfbiopharmaceutical / pain / GABAWet-LabGLPGMPklinische Studien
- Allecra Therapeutics2 shared techsBerlinbiopharmaceutical / antibiotics / multi-drug-resistanceWet-LabKlinische StudienGMP
- Apogenix2 shared techsHeidelbergbiopharmaceutical / immunoonkologieProtein-EngineeringGMPklinische Studien
- MerLion Pharmaceuticals2 shared techsBerlinbiopharmaceutical / antibioticsAntibiotika-EntwicklungGMPklinische Studien
- Paion2 shared techsAachenpharmaceutical / sedationKlinische StudienGMPRegulatory-Compliance
- Vaximm2 shared techsMannheimbiopharmaceutical / cancer-immunotherapy / oral-vaccinesBakterielle VektorenGMPklinische Studien
Same location
Local tech ecosystem
Consulting on this stack
Working with a similar stack?
We help companies like this build data-driven platforms — from AI research to production deploy.